Yani He

Prof. Yani He


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2015 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Closed access
PDF file
JLJun Liu
Jun Liu
JYJu-Rong Yang
Ju-Rong Yang
XCXiang-Mei Chen
Xiang-Mei Chen
GCGuang-Yan Cai
Guang-Yan Cai
LLLi-Rong Lin
Li-Rong Lin
YHYani He
Yani He
Premature senescence is an important event during diabetic nephropathy (DN) progression. Here, we investigated the role of endoplasmic reticulum (ER) stress-regulated activation of transcription factor 4 (ATF4)/p16 signaling in the premature senescence of renal tubular epithelial cells (RTECs) during DN development. In the renal tissues of Type 2 DN patients, we detected an increased number of senescent cells; elevated deposition of advanced glycation end products (AGEs); upregulated expression of ER stress marker, glucose-regulated protein 78; as well as overexpression of ATF4 and p16. Similarly, these phenomena were also observed in cultured mouse RTECs following AGE treatment. Interestingly, AGE-induced p16 expression and premature senescence were successfully attenuated by ER stress inhibitor and ATF4 gene silencing. Moreover, AGE-induced premature senescence was mimicked by ER stress inducers and ATF4 overexpression, while suppressed by p16 gene silencing. In addition, ER stress inducers can augment ATF4 expression. Therefore, our results demonstrate that the ER stress-regulated ATF4/p16 pathway is involved in the premature senescence of RTECs during DN progression.

1 September 2020 in Kidney International
Verified
Journal Article
Open access
CJChen Jia
Chen Jia
CKChen Ke-Hong
Chen Ke-Hong
XFXiao Fei
Xiao Fei
DHDai Huan-Zi
Dai Huan-Zi
YJYang Jie
Yang Jie
YHYani He
Yani He
Premature senescence of renal tubular epithelial cell (RTEC), which is involved in kidney fibrosis, is a key event in the progression of diabetic nephropathy. However, the underlying mechanism remains unclear. Here we investigated the role and mechanism of decoy receptor 2 (DcR2) in kidney fibrosis and the senescent phenotype of RTEC. DcR2 was specifically expressed in senescent RTEC and associated with kidney fibrosis in patients with diabetic nephropathy and mice with streptozotocin-induced with diabetic nephropathy. Knockdown of DcR2 decreased the expression of α-smooth muscle actin, collagen I, fibronectin and serum creatinine levels in streptozotocin-induced mice. DcR2 knockdown also inhibited the expression of senescent markers p16, p21, senescence-associated beta-galactosidase and senescence-associated heterochromatic foci and promoted the secretion of a senescence-associated secretory phenotype including IL-6, TGF-β1, and matrix metalloproteinase 2 in vitro and in vivo. However, DcR2 overexpression showed the opposite effects. Quantitative proteomics and validation studies revealed that DcR2 interacted with peroxiredoxin 1 (PRDX1), which regulated the cell cycle and senescence. Knockdown of PRDX1 upregulated p16 and cyclin D1 while downregulating cyclin-dependent kinase 6 expression in vitro, resulting in RTEC senescence. Furthermore, PRDX1 knockdown promoted DcR2-induced p16, cyclin D1, IL-6, and TGF-β1 expression, whereas PRDX1 overexpression led to the opposite results. Subsequently, DcR2 regulated PRDX1 phosphorylation, which could be inhibited by the specific tyrosine kinase inhibitor genistein. Thus, DcR2 mediated the senescent phenotype of RTEC and kidney fibrosis by interacting with PRDX1. Hence, DcR2 may act as a potential therapeutic target for the amelioration of diabetic nephropathy progression.

25 April 2018 in Frontiers of Medicine
Verified
Journal Article
Closed access
PDF file
BFBiqiong Fu
Biqiong Fu
JYJie Yang
Jie Yang
JCJia Chen
Jia Chen
LLLirong Lin
Lirong Lin
KCKehong Chen
Kehong Chen
YHYani He
Yani He

21 May 2020 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
KCKehong Chen
Kehong Chen
JCJia Chen
Jia Chen
LWLing Wang
Ling Wang
JYJie Yang
Jie Yang
FXFei Xiao
Fei Xiao
YHYani He
Yani He
Renal tubular injury contributes to the progression of diabetic nephropathy ( DN). This study explored the role and mechanisms of E3‐ubiquitin ligase Parkin in the renal tubular injury of DN. We found that Parkin expression gradually decreased and was inversely associated with IL‐6, TGF‐β1, and GATA4 expression in the kidney during the progression of DN. Parkin over‐expression (OE) reduced inflammation, fibrosis, premature senescence of renal tubular epithelial cells (RTECs), and improved renal function while Parkin knockout (KO) had opposite effects in DN mice. Parkin‐OE decreased GATA4 protein, but not its mRNA transcripts in the kidney of DN mice and high glucose (HG)‐treated RTECs. Immunoprecipitation indicated that Parkin directly interacted with GATA4 in DN kidney. Parkin‐OE enhanced GATA4 ubiquitination. Furthermore, Parkin‐KO upregulated growth arrest‐specific gene 1 (GAS1) expression in renal tubular tissues of DN mice and GATA4‐OE enhanced the HG‐upregulated GAS1 expression in RTECs. Conversely, GAS1‐OE mitigated the effect of Parkin‐OE on HG‐induced P21, IL‐6, and TGF‐β1 expression in RTECs. These results indicate that Parkin inhibits the progression of DN by promoting GATA4 ubiquitination and downregulating the GATA4/GAS1 signaling to inhibit premature senescence, inflammation, and fibrosis in DN mice. Thus, these findings uncover new mechanisms underlying the action of Parkin during the process of DN.

12 August 2022 in The FASEB Journal
Verified
Journal Article
Closed access
JCJia Chen
Jia Chen
HLHongxiang Lu
Hongxiang Lu
XWXiaoyue Wang
Xiaoyue Wang
JYJie Yang
Jie Yang
JLJia Luo
Jia Luo
KCKe-hong Chen
Ke-hong Chen

3 June 2022 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
JCJia Chen
Jia Chen
KCKe-Hong Chen
Ke-Hong Chen
LWLi-Ming Wang
Li-Ming Wang
JLJia Luo
Jia Luo
QZQuan-You Zheng
Quan-You Zheng
YHYani He
Yani He
Apoptotic resistance leads to persistent accumulation of senescent cells and sustained expression of a senescence-associated secretory phenotype, playing an essential role in the progression of tissue fibrosis. However, whether senescent renal tubular epithelial cells (RTECs) exhibit an apoptosis-resistant phenotype, and the role of this phenotype in diabetic nephropathy (DN) remain unclear. Our previous study was the first to demonstrate that decoy receptor 2 (DcR2) is associated with apoptotic resistance in senescent RTECs and renal fibrosis. In this study, we aimed to further explore the mechanism of DcR2 in apoptosis-resistant RTECs and renal fibrosis in DN. DcR2 was co-localized with fibrotic markers (α-SMA, collagen IV, fibronectin), senescent marker p16, and antiapoptotic proteins FLIP and Bcl2 but rarely co-localized with caspase 3 or TUNEL. DcR2 overexpression promoted renal fibrosis in mice with streptozotocin (STZ)-induced DN, as evidenced by augmented Masson staining and upregulated expression of fibrotic markers. DcR2 overexpression also enhanced FLIP expression while reducing the expression of pro-apoptotic proteins (caspases 8 and 3) in senescent RTECs, resulting in apoptotic resistance. In contrast, DcR2 knockdown produced the opposite effects in vitro and in vivo. Moreover, quantitative proteomics and co-immunoprecipitation experiments demonstrated that DcR2 interacted with glucose-related protein 78 kDa (GRP78), which has been shown to promote apoptotic resistance in cancer. GRP78 exhibited co-localization with senescent and antiapoptotic markers but was rarely co-expressed with caspase 3 or TUNEL. Additionally, GRP78 knockdown decreased the apoptosis resistance of HG-induced senescent RTECs with upregulated cleaved caspase 3 and increased the percentage of apoptotic RTECs. Mechanistically, DcR2 mediated apoptotic resistance in senescent RTECs by enhancing GRP78–caspase 7 interactions and promoting Akt phosphorylation. Thus, DcR2 mediated the apoptotic resistance of senescent RTECs and renal fibrosis by interacting with GRP78, indicating that targeting the DcR2–GRP78 axis represents a promising therapeutic strategy for DN.